Aymanshafei (Talk | contribs) |
Aymanshafei (Talk | contribs) |
||
Line 180: | Line 180: | ||
</section> | </section> | ||
<!-- /#header --> | <!-- /#header --> | ||
+ | <div class="twitter-feed purple"> | ||
+ | <div class="container section-wrapper"> | ||
+ | <video width="420" height="340" controls style="border:1px solid #000"> | ||
+ | <source src="asset/video/movie.ogg" type="video/ogg"> | ||
+ | <source src="asset/video/movie.mp4" type="video/mp4"> | ||
+ | </video> | ||
+ | |||
+ | </div> | ||
+ | |||
+ | </div> | ||
+ | |||
+ | |||
+ | |||
+ | |||
<div class="twitter-feed purple" style="margin-bottom:50vh;background-color: rgba(0, 0, 0, 0.4);"> | <div class="twitter-feed purple" style="margin-bottom:50vh;background-color: rgba(0, 0, 0, 0.4);"> |
Revision as of 14:19, 21 October 2017
Abstract
Competing endogenous RNA network : Potential entrants to gene editing in Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers
in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-.
"Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique
that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma.
This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials.
This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials. This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.